Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.05
-0.09 (-1.26%)
Pre-market: Mar 10, 2026, 9:08 AM EDT
Edesa Biotech Revenue
Edesa Biotech had revenue of $102.43K in the quarter ending December 31, 2025, a decrease of -65.99%. This brings the company's revenue in the last twelve months to $585.12K, down -33.41% year-over-year. In the fiscal year ending September 30, 2025, Edesa Biotech had annual revenue of $783.89K with 12.26% growth.
Revenue (ttm)
$585.12K
Revenue Growth
-33.41%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
59.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 783.89K | 85.62K | 12.26% |
| Sep 30, 2024 | 698.28K | 117.24K | 20.18% |
| Sep 30, 2023 | 581.04K | -199.22K | -25.53% |
| Sep 30, 2022 | 780.26K | -9.56M | -92.45% |
| Sep 30, 2021 | 10.34M | 10.01M | 3,045.01% |
| Sep 30, 2020 | 328.80K | 116.95K | 55.21% |
| Sep 30, 2018 | 211.85K | -16.44K | -7.20% |
| Sep 30, 2017 | 228.29K | -1.04M | -82.05% |
| Sep 30, 2016 | 1.27M | 513.00K | 67.62% |
| Sep 30, 2015 | 758.69K | 386.56K | 103.88% |
| Aug 31, 2014 | 372.13K | -173.34K | -31.78% |
| Aug 31, 2013 | 545.47K | 259.42K | 90.69% |
| Aug 31, 2012 | 286.05K | -411.13K | -58.97% |
| Aug 31, 2011 | 697.19K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImmuCell | 27.64M |
| Metagenomi Therapeutics | 25.21M |
| Alterity Therapeutics | 4.43M |
| NeurAxis | 3.36M |
| BeyondSpring | 1.88M |
| Entera Bio | 124.00K |
| eXoZymes | -700.00 |
EDSA News
- 13 days ago - Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewsWire
- 24 days ago - Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - GlobeNewsWire
- 3 months ago - Edesa Biotech Reports Fiscal Year 2025 Results - GlobeNewsWire
- 4 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 4 months ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 7 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire
- 10 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewsWire
- 11 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewsWire